Tissue responses to ischemia: Local and remote responses for preserving perfusion of ischemic muscle

Journal of Clinical Investigation

Volumn 106, Issue 5, 2000, Pages 615-619

  Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; MUSCLE PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE OXYGENATION;

EID: 0033823130     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10961     Document Type: Review

References (41)

1. Avivi, A., Resnick, M.B., Nevo, E., Joel, A., and Levy, A.P. 1999. Adaptive hypoxic tolerance in the subterranean mole rat Spalax ehrenbergi: the role of vascular endothelial growth factor. FEBS Lett. 452:133-140.
2. 165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation. 102:965-974.
3. Couffinhal, T., et al. 1998. A mouse model of angiogenesis. Am. J. Pathol. 152:1667-1679.
4. Li, J., et al. 1996. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270:H1803-H1811.
5. Lee, S. H., et al. 2000. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:626-633.
6. Ikeda. H.Y., et al. 2000. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 35:968-973.
7. D'Arcangelo, D., et al. 2000. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor expression. Circ. Res. 86:312-318.
8. Forsythe, J.A., et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
9. Shima, D. T., Deutsch, U., and D'Amore, P.A. 1995. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 370:203-208.
10. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15:5363-5368.
11. Levy, A.P., et al. 1995. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ. Res. 76:758-766.
12. Couffinhal, T., et al. 1999. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE mice. Circulation. 99:3188-3198.
13. Arras, M., et al. 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101:40-50.
14. Freeman, M.R., et al. 1995. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55:4140-4145.
15. Kalka, C., et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA. 97:3422-3427.
16. Brogi, E., et al. 1996. Hypoxia-induced paracrine regulation of VEGF receptor expression. J. Clin. Invest. 97:469-476.
17. Murohara, T., et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:2567-2578.
18. Ziche, M., et al. 1997. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99:2625-2634.
19. Tsurumi, Y., et al. 1997. Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity. Nat. Med. 3:879-886.
20. Drake, C.J., and Little, C.D. 1995. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad Sci. USA. 92:7657-7661.
21. White, E.C., Carroll, S.M., Magnet, A., and Bloor, C.M. 1992. Coronary collateral development in swine after coronary artery occlusion. Circ. Res. 71:1490-1500.
22. Takeshira, S., et al. 1997. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation. 95:805-808.
23. Mandriota, S.J., and Pepper, M.S. 1998. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83:852-859.
24. Brogi, E., Wu, T., Namiki, A., and Isner, J.M. 1994. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, while hypoxia upregulates VEGF expression only. Circulation. 90:649-652.
25. Breier, G., Albrecht, U., Sterrer, S., and Risau, W. 1992. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 114:521-532.
26. Shi, Q., et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood. 92:362-367.
27. Takahashi, T., et al. 1999. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434-438.
28. Rivard, A., et al. 1999. Age-dependent impairment of angiogenesis. Circulation. 99:111-120.
29. Rivard, A., et al. 2000. Age-dependent defect in VEGF expression is associated with reduced HIF-1 activity. J. Biol. Chem. In press.
30. Frenkel-Denkberg, G., Gershon, D., and Levy, A.P. 1999. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett. 462:341-344.
31. 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86:1198-1202.
32. Van Belle, E., et al. 1997. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation. 96:2667-2674.
33. Vincent, K.A., et al. 2000. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding a HIF-1α/VP16 hybrid transcription factor. Circulation. In press.
34. Rivard, A., et al. 1999. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154:355-364.
35. Abaci, A., et al. 1999. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 99:2239-2242.
36. Rohan, R.M., Fernandez, A., Udagawa, T., Yuan, J., and D'Amato, R.J. 2000. Genetic heterogeneity of angiogenesis in mice. FASEB J. 14:871-876.
37. Schultz, A., et al. 1999. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation. 100:547-552.
38. 188. Nat. Med. 5:495-502.
39. Marti, H., and Risau, W. 1998. Systemic hypoxia changes the organ specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA. 95:15809-15814.
40. Peterson, A., et al. 2000. Heterogeneity of the angiogenic factor/vascular endothelial growth factor. Lab. Invest. 80:99-115.
41. Hanahan, D., and Folkman, J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353-364.